Anna Baran

1.9k total citations
92 papers, 967 citations indexed

About

Anna Baran is a scholar working on Immunology, Molecular Biology and Dermatology. According to data from OpenAlex, Anna Baran has authored 92 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 31 papers in Molecular Biology and 26 papers in Dermatology. Recurrent topics in Anna Baran's work include Psoriasis: Treatment and Pathogenesis (38 papers), Dermatology and Skin Diseases (15 papers) and Autoimmune Bullous Skin Diseases (10 papers). Anna Baran is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (38 papers), Dermatology and Skin Diseases (15 papers) and Autoimmune Bullous Skin Diseases (10 papers). Anna Baran collaborates with scholars based in Poland, United States and Germany. Anna Baran's co-authors include Iwona Flisiak, Julia Nowowiejska, Hanna Myśliwiec, Magdalena Świderska, Elżbieta Kowalska-Olędzka, Magdalena Czarnecka, Tomasz W. Kamiński, Piotr Myśliwiec, Anna Justyna Milewska and Ewa Harasim‐Symbor and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecular and Cellular Endocrinology.

In The Last Decade

Anna Baran

83 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Baran Poland 18 511 319 313 102 95 92 967
Hani A. Al‐Shobaili Saudi Arabia 21 247 0.5× 240 0.8× 194 0.6× 92 0.9× 174 1.8× 44 830
Alessia Pacifico Italy 23 483 0.9× 658 2.1× 149 0.5× 165 1.6× 82 0.9× 64 1.3k
Iwona Flisiak Poland 22 800 1.6× 367 1.2× 510 1.6× 196 1.9× 135 1.4× 143 1.5k
Mariusz Sikora Poland 21 255 0.5× 450 1.4× 382 1.2× 221 2.2× 75 0.8× 62 1.3k
Hanna Myśliwiec Poland 16 273 0.5× 141 0.4× 262 0.8× 145 1.4× 48 0.5× 50 707
Spyridon Christodoulou Greece 14 302 0.6× 70 0.2× 233 0.7× 105 1.0× 50 0.5× 30 975
Sergio Di Nuzzo Italy 15 241 0.5× 259 0.8× 77 0.2× 104 1.0× 37 0.4× 48 626
H. Y. A. Lau Hong Kong 20 486 1.0× 107 0.3× 307 1.0× 385 3.8× 88 0.9× 65 1.2k
Yu‐Huei Huang Taiwan 17 359 0.7× 329 1.0× 91 0.3× 91 0.9× 105 1.1× 66 846
Kevin O’Brien United States 21 191 0.4× 100 0.3× 323 1.0× 342 3.4× 173 1.8× 62 1.3k

Countries citing papers authored by Anna Baran

Since Specialization
Citations

This map shows the geographic impact of Anna Baran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Baran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Baran more than expected).

Fields of papers citing papers by Anna Baran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Baran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Baran. The network helps show where Anna Baran may publish in the future.

Co-authorship network of co-authors of Anna Baran

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Baran. A scholar is included among the top collaborators of Anna Baran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Baran. Anna Baran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baran, Anna, et al.. (2025). Friend or foe? Sebaceous cyst inflammation during ixekizumab therapy in psoriatic arthritis: case based review. Rheumatology International. 45(9). 193–193. 1 indexed citations
2.
3.
Baran, Anna, et al.. (2025). Peripheral Kynurenine Pathway Metabolites in Patients with Psoriasis. International Journal of Molecular Sciences. 26(7). 3139–3139.
4.
Nowowiejska, Julia, Anna Baran, Anna Pryczynicz, et al.. (2024). Gasdermin B (GSDMB) in psoriatic patients–a preliminary comprehensive study on human serum, urine and skin. Frontiers in Molecular Biosciences. 11. 1382069–1382069. 4 indexed citations
5.
Baran, Anna, et al.. (2024). A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation. International Journal of Molecular Sciences. 25(6). 3482–3482. 2 indexed citations
6.
Baran, Anna, et al.. (2024). Smoking, alcohol, substance, technology, and gambling addiction among university students. European Journal of Public Health. 34(Supplement_3).
7.
Baran, Anna, et al.. (2023). Kynurenine Pathway in Psoriasis—a Promising Link?. Dermatology and Therapy. 13(8). 1617–1627. 5 indexed citations
8.
Nowowiejska, Julia, Anna Baran, Anna Pryczynicz, et al.. (2023). Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue. Cells. 12(17). 2149–2149. 10 indexed citations
9.
Nowowiejska, Julia, et al.. (2023). Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications. Biomolecules. 13(10). 1472–1472. 6 indexed citations
10.
Baran, Anna, et al.. (2023). Hand Eczema in the Polish Female Population. Journal of Clinical Medicine. 12(18). 6102–6102. 1 indexed citations
11.
Nowowiejska, Julia, Anna Baran, Justyna Magdalena Hermanowicz, et al.. (2023). Gasdermin C (GSDMC) is Overexpressed in Psoriatic Tissue and Elevated in Psoriatic Serum: A Potential Marker of Cell Proliferation and Local Hypoxia in Psoriasis?. Dermatologic Therapy. 2023(1). 2 indexed citations
12.
Nowowiejska, Julia, Anna Baran, & Iwona Flisiak. (2023). The first case of the exacerbation of psoriatic skin lesions after liraglutide. Polskie Archiwum Medycyny Wewnętrznej. 133(7-8). 4 indexed citations
13.
Nowowiejska, Julia, Anna Baran, Bartosz Woźniak, et al.. (2023). Dry eye syndrome symptoms in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. 38(8). 1522–1530. 1 indexed citations
14.
Baran, Anna, et al.. (2020). Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis. International Journal of Molecular Sciences. 21(13). 4594–4594. 13 indexed citations
15.
Myśliwiec, Hanna, Beata Żelazowska‐Rutkowska, Anna Baran, et al.. (2018). [Vitamin D deficiency in psoriatic patients in north-east of Poland].. PubMed. 73(9). 610–4. 2 indexed citations
16.
Myśliwiec, Hanna, et al.. (2017). Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelas. PubMed. 70(4). 575–584. 12 indexed citations
17.
Baran, Anna, et al.. (2017). The role of lipids in psoriasis. Dermatology Review. 104(6). 619–635. 15 indexed citations
18.
Baran, Anna, et al.. (2013). Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) – case report. 100(1). 31–35. 1 indexed citations
19.
Baran, Anna, Iwona Flisiak, & Bożena Chodynicka. (2012). Rare coexistence of psoriasis, lichen sclerosus and morphea – case report and literature data. 99(1). 39–44. 1 indexed citations
20.
Baran, Anna, Iwona Flisiak, Hanna Myśliwiec, & Bożena Chodynicka. (2011). Role of adiponectin in psoriasis. 97(6). 413–416. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026